Diabetic retinopathy develops when chronically high blood sugar damages the blood vessels lining the back of the eye and affects nearly 10 million people in the U.S
Its important to note, this analysis was written before the SELECT trial, which showed a 20% reduction in major adverse cardiovascular events among people with prior cardiovascular disease
Weight Loss: Comparable to Bariatric Outcomes Tirzepatide has shown an unprecedented effect on body weight among antidiabetic drugs: Average weight loss of 10.515 kg (2333 lbs) in type 2 diabetes patients Even greater results (up to 22.5% body weight reduction) in non-diabetic individuals with obesity, per the SURMOUNT-1 trial This places Tirzepatide in competition with dedicated weight-loss medications and even some bariatric procedures, making it a dual-action solution for metabolic disease
Evans JL, Heymann CJ, Goldfine ID, Gavin LA
Effect of Glycemic Control on Cutaneous Microenvironment GLP-1 RAs limit gastric motility and promote better glycemic control
the pilar unit, which contains the hair follicle and papillae
